icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 20 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

Drug Clinical Trials List

Display 461 - 470 from 768
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial King Abdulaziz University Hospital Rejected Misoprostol 2 227-15 King Abdulaziz University Hospital (Jeddah)
"A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus" MSD Terminated MK-0431A (Sitagliptin / Metformin) vs Liraglutide 3 MK-0431A-180-00 King Khalid University Hospital (Riyadh)
"Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients" Astellas Completed • Micafungin• Fluconazole• Liposomal Amphotericin B• Caspofungin 3b 9463EC0001 King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients Alcon Completed Travoprost 0.004% 1 C-12-009 King Khaled Eye Specialist Hospital (Riyadh)
A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease. Eli Lilly Terminated Prasugrel 3 H7T-MC-TADO King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh)
A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) Merck Serono Terminated Lutropin alfa 3b EMR200061_506 King Abdulaziz University Hospital (Jeddah)
SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety SPIMACO Terminated Fastulin R / Normulin N 3 (version 1.4) Aug 2011 King Fahad Medical City (Riyadh)
"A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes " Sanofi Terminated GLIMEPIRIDE-HOE490 3 GLIME_R_05809 King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh)
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study. Servier Terminated Ivabradine 3 CL3-16257-083 King Fahad Medical City (Riyadh)
A Randomized Study of the Effect of Maintenance Therapy With Bevacizumab + Capecitabine Versus Bevacizumab Alone on Progression-free Survival in Patients With HER2-negative Metastatic Breast Cancer That Has Not Progressed During First-line Docetaxel Plus Bevacizumab Therapy Roche Terminated Bevacizumab+ Capecitabine 3 MO22223 King Abdulaziz Hospital and Oncology Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)